A second chemotherapy cycle before haematopoietic stem cell transplantation (HSCT) may improve survival in children with relapsed AML. A retrospective analysis of data from the Australasian Bone Marrow Transplant Recipient Registry between 1998 and 2013 found two chemotherapy cycles improved overall survival compared to just one or three or more cycles. Two cycles appeared to ...
Already a member?
Enter your email to keep reading.